期刊文献+

基质金属蛋白酶及其抑制剂与喉癌的浸润和转移 被引量:1

原文传递
导出
摘要 喉癌是头颈部常见的恶性肿瘤,喉癌的浸润与转移是影响治疗效果和预后的主要因素。基质金属蛋白酶及基质金属蛋白酶抑制剂是调节许多生理和病理过程中细胞外基质及基底膜有序降解和重塑的重要分子。细胞外基质和基底膜的降解在喉癌和其他肿瘤的浸润转移过程中起重要作用,基质金属蛋白酶及其抑制剂在细胞外基质和基底膜的代谢平衡中起关键作用,因而与喉癌的浸润转移密切相关。本文对基质金属蛋白酶及其抑制剂在喉癌中的表达与喉癌浸润转移及预后的相关性作一综述,并对指导喉癌治疗进行了展望。
出处 《国际耳鼻咽喉头颈外科杂志》 2007年第3期174-177,共4页 International Journal of Otolaryngology-Head and Neck Surgery
  • 相关文献

参考文献19

  • 1Kanayama HO, Yokota K, Kurokaw a Y, et al. Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer. Cancer, 1998, 82 (7) : 1359-1366.
  • 2Itoh Y, Nagase H. Matrix metalloproteinases in cancer. Essays Biochem, 2002, 38 (1) : 21-36.
  • 3Woessner JF Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J, 1991, 5 (8) 2145-2154.
  • 4Visse R, Hideaki N. Matrix metalloproteinases and tissue inhibitors of metalloproteinases structure, function, and biochemistry. Cire Res, 2003, 92 (8):827-893.
  • 5Seo Dw, Li H, Guedez L, et al. TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism. Cell, 2003, 114 (2) : 171-180.
  • 6Magary SP, Ryan MW, Tarnuzzer RW, et al. Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in laryngeal and pharyngeal squamous cell carcinoma. A quantitative analysis. Otolaryngol Head Neck Surg, 2000, 122 (5) : 712-716.
  • 7Krecicki T, Fraczek M, Jelen M, et al. Expression of collagenase-1 (MMP-1) , collagenase-3 (MMP-13) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in laryngealsquamous cell carcinomas. Eur Arch Otorhinolaryngol, 2003, 260 (9):494-497.
  • 8Cazorla M, Hemandez L, Nadal A, et al. Collagenase-3 expression is associated with advanced local invasion in human squamous cell carcinomas of the larynx. J Pathol, 1998, 186 (5) : 144-150.
  • 9Bogusiewicz M, Stryjecka-Zimmer M, Szymanski M, et al. Activity of matrix metalloproteinases-2 and-9 in advanced laryngeal cancer. Otolaryngol Head Neck Surg, 2003, 128 (1) : 132-136.
  • 10Tokumaru Y, Fujii M, Otani Y, et al. Activation of matrix metalloproteinase-2 in head and neck squamous cell carcinoma: studies of clinical samples and in vitro cell lines co-cultured with fibroblasts. Cancer Lett, 2000, 150 (1) : 15-21.

二级参考文献4

共引文献1

同被引文献11

  • 1李为,刘卫卫,白文忠,施惠晶.MMP-7和TIMP-1在喉癌中的表达[J].中国耳鼻咽喉头颈外科,2007,14(7):406-406. 被引量:1
  • 2Galardy RE. Galardin[J], Drugs Future,1993, 18 ( 12):1109-1111.
  • 3Grobelny D,Poncz L,Galardy RE. Inhibition of humanskin fibroblast collagenase,thermolysin, and Pseudo-monas aeruginosa elastase by peptide hydroxamic acids[J]. Biochemistry, 1992,31 (20) :7152-7154.
  • 4Bode W,Fernandez-Catalan C,Tschesche,et al. Structuralproperties of matrix metalloproteinases [J]. Cell MollifeSci,1999,55(4):639-652.
  • 5Suarez-Cuetwo C,Merrell MA, Watson I,et al. Breastcancer cells with inhibition of p38alpha have decreasedMMP-9 activity and exhibit decreased bone metastasis inmice[J]. Clin Exp Metastasis,2004,21(6) : 525-533.
  • 6Xu D, McKee CM, Cao Y, et al. Matrix metalloproteinase-9regulates tumor cell invasion through cleavage of proteasenexin-l[J]. Cancer research,2010,70(17) :6988-6998.
  • 7Sun Y,Liu M, Yang B,et al. Inhibition of laryngeal cancercell invasion and growth with lentiviral-vector deliveredshort hairpin RNA targeting human MMP-9 gene [ J].Cancer invest,2008,26(10) :984-989.
  • 8Almholt K,Juncker-Jensen A,Lorum OD,et al. Metastasis is strongly reduced by the matrixmetalloproteinase inhibitor Galardin in the MMTV-PymTtransgenic breast cancer model[J], Molecular cancer ther-apeutics ,2008,7(9):2758-2767.
  • 9Hao JL, Nagano T,Nakamura M, et al. Galardin inhibitscollagen degradation by rabbit keratocytes by inhibitingthe activation of pro-matrix metalloproteinases [ J]. ExpEye Res,1999,68(5) :565-572.
  • 10黄万钟,姚月华,钟瑜,鲍洁,潘达超.长春瑞滨联合卡培他滨治疗难治性鼻咽癌的临床观察[J].中国实用医药,2009,4(34):30-31. 被引量:1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部